These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25979701)

  • 1. CSF proteins and resting-state functional connectivity in Parkinson disease.
    Campbell MC; Koller JM; Snyder AZ; Buddhala C; Kotzbauer PT; Perlmutter JS
    Neurology; 2015 Jun; 84(24):2413-21. PubMed ID: 25979701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson's disease.
    Abbasi N; Mohajer B; Abbasi S; Hasanabadi P; Abdolalizadeh A; Rajimehr R
    Mov Disord; 2018 Mar; 33(3):431-439. PubMed ID: 29436735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinopathy and longitudinal changes in functional connectivity networks in Parkinson disease.
    Campbell MC; Jackson JJ; Koller JM; Snyder AZ; Kotzbauer PT; Perlmutter JS
    Neurology; 2020 Feb; 94(7):e718-e728. PubMed ID: 31852813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
    Buddhala C; Campbell MC; Perlmutter JS; Kotzbauer PT
    Neurobiol Aging; 2015 Jan; 36(1):476-84. PubMed ID: 25212463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42.
    Sheline YI; Morris JC; Snyder AZ; Price JL; Yan Z; D'Angelo G; Liu C; Dixit S; Benzinger T; Fagan A; Goate A; Mintun MA
    J Neurosci; 2010 Dec; 30(50):17035-40. PubMed ID: 21159973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF biomarkers and clinical progression of Parkinson disease.
    Hall S; Surova Y; Öhrfelt A; Zetterberg H; Lindqvist D; Hansson O
    Neurology; 2015 Jan; 84(1):57-63. PubMed ID: 25411441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease.
    Skogseth RE; Bronnick K; Pereira JB; Mollenhauer B; Weintraub D; Fladby T; Aarsland D
    J Parkinsons Dis; 2015; 5(4):783-92. PubMed ID: 26599300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
    Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
    Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Pagano G; De Micco R; Yousaf T; Wilson H; Chandra A; Politis M
    Neurology; 2018 Sep; 91(10):e894-e905. PubMed ID: 30089615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.
    Kim HJ; Cha J; Lee JM; Shin JS; Jung NY; Kim YJ; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2016; 50(3):709-18. PubMed ID: 26757039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
    Schöll M; Wall A; Thordardottir S; Ferreira D; Bogdanovic N; Långström B; Almkvist O; Graff C; Nordberg A
    Neurology; 2012 Jul; 79(3):229-36. PubMed ID: 22700814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigrostriatal dopamine-independent resting-state functional networks in Parkinson's disease.
    Ham JH; Cha J; Lee JJ; Baek GM; Sunwoo MK; Hong JY; Shin NY; Sohn YH; Lee JM; Lee PH
    Neuroimage; 2015 Oct; 119():296-304. PubMed ID: 26143204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.
    Vilas D; Shaw LM; Taylor P; Berg D; Brockmann K; Aasly J; Marras C; Pont-Sunyer C; Ríos J; Marek K; Tolosa E
    Mov Disord; 2016 Jun; 31(6):906-14. PubMed ID: 27041685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity.
    van Dijk KD; Bidinosti M; Weiss A; Raijmakers P; Berendse HW; van de Berg WD
    Eur J Neurol; 2014 Mar; 21(3):388-94. PubMed ID: 23631635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability.
    Elman JA; Madison CM; Baker SL; Vogel JW; Marks SM; Crowley S; O'Neil JP; Jagust WJ
    Cereb Cortex; 2016 Feb; 26(2):695-707. PubMed ID: 25405944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.
    Schultz AP; Chhatwal JP; Hedden T; Mormino EC; Hanseeuw BJ; Sepulcre J; Huijbers W; LaPoint M; Buckley RF; Johnson KA; Sperling RA
    J Neurosci; 2017 Apr; 37(16):4323-4331. PubMed ID: 28314821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disrupted Intrinsic Networks Link Amyloid-β Pathology and Impaired Cognition in Prodromal Alzheimer's Disease.
    Koch K; Myers NE; Göttler J; Pasquini L; Grimmer T; Förster S; Manoliu A; Neitzel J; Kurz A; Förstl H; Riedl V; Wohlschläger AM; Drzezga A; Sorg C
    Cereb Cortex; 2015 Dec; 25(12):4678-88. PubMed ID: 24996404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer's disease.
    Myers N; Pasquini L; Göttler J; Grimmer T; Koch K; Ortner M; Neitzel J; Mühlau M; Förster S; Kurz A; Förstl H; Zimmer C; Wohlschläger AM; Riedl V; Drzezga A; Sorg C
    Brain; 2014 Jul; 137(Pt 7):2052-64. PubMed ID: 24771519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia.
    Vijayaraghavan S; Maetzler W; Reimold M; Lithner CU; Liepelt-Scarfone I; Berg D; Darreh-Shori T
    Alzheimers Dement; 2014 Sep; 10(5):530-540.e1. PubMed ID: 23978325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.